Detalhe da pesquisa
1.
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
Ann Surg Oncol
; 29(2): 791-801, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648098